EASE (Efficacy of ATX01 Study in Erythromelalgia)

Clinical trial NCT05917912 · COMPLETED

Trial details

NCT number: NCT05917912
Sponsor: AlgoTherapeutix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Erythromelalgia

Start date: 2023-06-14
Primary completion: 2024-02-29
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.